Harnessing Novel Quantitative Pharmacology Approaches to Optimize the Treatment of Children With Tuberculosis

por Seddon, James A., Makhene, Mamodikoe K.
Publicado 2016

Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead

por Gumbo, Tawanda, Makhene, Mamodikoe K., Seddon, James A.
Publicado 2016

Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers

por Li, Mengchun, Saviolakis, George A., El‐Amin, Wael, Makhene, Mamodikoe K., Osborn, Blaire, Nedelman, Jerry, Yang, Tian J., Everitt, Daniel
Publicado 2020

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial

por Branche, Angela R., Rouphael, Nadine G., Losada, Cecilia, Baden, Lindsey R., Anderson, Evan J., Luetkemeyer, Anne F., Diemert, David J., Winokur, Patricia L., Presti, Rachel M., Kottkamp, Angelica C., Falsey, Ann R., Frey, Sharon E., Rupp, Richard, Bäcker, Martín, Novak, Richard M., Walter, Emmanuel B., Jackson, Lisa A., Little, Susan J., Immergluck, Lilly C., Mahgoub, Siham M., Whitaker, Jennifer A., Babu, Tara M., Goepfert, Paul A., Fusco, Dahlene N., Atmar, Robert L., Posavad, Christine M., Netzl, Antonia, Smith, Derek J., Telu, Kalyani, Mu, Jinjian, Makowski, Mat, Makhene, Mamodikoe K., Sonja, Crandon, Montefiori, David C., Roberts, Paul C., Beigel, John H.
Publicado 2023